Quotient (NASDAQ:QTNT) announced its earnings results on Tuesday. The company reported ($0.41) EPS for the quarter, topping the Zacks’ consensus estimate of ($0.44) by $0.03, Fidelity Earnings reports. Quotient updated its FY 2020 guidance to EPS.
QTNT opened at $10.06 on Wednesday. Quotient has a 52-week low of $5.52 and a 52-week high of $11.15. The company has a debt-to-equity ratio of 4.95, a current ratio of 6.87 and a quick ratio of 6.05. The firm has a market cap of $611.30 million, a P/E ratio of -4.98 and a beta of 1.25.
A number of equities analysts have recently commented on QTNT shares. BidaskClub upgraded Quotient from a “hold” rating to a “buy” rating in a report on Tuesday, January 29th. ValuEngine upgraded Quotient from a “buy” rating to a “strong-buy” rating in a report on Saturday, February 2nd. Jefferies Financial Group boosted their price objective on Quotient from $11.00 to $13.50 and gave the company a “buy” rating in a report on Tuesday, March 5th. Finally, Zacks Investment Research cut Quotient from a “hold” rating to a “sell” rating in a report on Thursday, April 4th. Two research analysts have rated the stock with a hold rating, two have assigned a buy rating and one has issued a strong buy rating to the stock. Quotient currently has a consensus rating of “Buy” and a consensus price target of $11.75.
A number of institutional investors and hedge funds have recently bought and sold shares of QTNT. Niemann Capital Management Inc. purchased a new stake in shares of Quotient in the 1st quarter worth $101,000. Resources Investment Advisors Inc. purchased a new stake in shares of Quotient in the 1st quarter worth $105,000. Dynamic Technology Lab Private Ltd purchased a new stake in shares of Quotient in the 1st quarter worth $124,000. SlateStone Wealth LLC purchased a new stake in shares of Quotient in the 4th quarter worth $91,000. Finally, Rehmann Capital Advisory Group purchased a new stake in shares of Quotient in the 1st quarter worth $154,000. Institutional investors own 65.82% of the company’s stock.
WARNING: “Quotient (QTNT) Releases Earnings Results, Beats Estimates By $0.03 EPS” was posted by Dakota Financial News and is owned by of Dakota Financial News. If you are viewing this story on another website, it was copied illegally and republished in violation of United States & international copyright and trademark law. The correct version of this story can be accessed at https://dakotafinancialnews.com/2019/05/29/quotient-qtnt-releases-earnings-results-beats-estimates-by-0-03-eps.html.
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and commercializes conventional reagent products used for blood grouping in the transfusion diagnostics market worldwide. The company is developing MosaiQ, a proprietary technology platform, which provides tests for blood grouping and serological disease screening.
Featured Story: Are sell-side analysts objective?
Receive News & Ratings for Quotient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quotient and related companies with MarketBeat.com's FREE daily email newsletter.